Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,059 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration.
Egerton A, Griffiths K, Casetta C, Deakin B, Drake R, Howes OD, Kassoumeri L, Khan S, Lankshear S, Lees J, Lewis S, Mikulskaya E, Millgate E, Oloyede E, Pollard R, Rich N, Segev A, Sendt KV, MacCabe JH. Egerton A, et al. Among authors: lees j. Neuropsychopharmacology. 2023 Feb;48(3):567-575. doi: 10.1038/s41386-022-01508-w. Epub 2022 Dec 1. Neuropsychopharmacology. 2023. PMID: 36456813 Free PMC article.
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study.
Millgate E, Griffiths K, Egerton A, Kravariti E, Casetta C, Deakin B, Drake R, Howes OD, Kassoumeri L, Khan S, Lankshear S, Lees J, Lewis S, Mikulskaya E, Oloyede E, Owens R, Pollard R, Rich N, Smart S, Segev A, Verena Sendt K, MacCabe J; STRATA Consortium. Millgate E, et al. Among authors: lees j. BMJ Open. 2022 Nov 21;12(11):e062570. doi: 10.1136/bmjopen-2022-062570. BMJ Open. 2022. PMID: 36410817 Free PMC article.
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
Egerton A, Murphy A, Donocik J, Anton A, Barker GJ, Collier T, Deakin B, Drake R, Eliasson E, Emsley R, Gregory CJ, Griffiths K, Kapur S, Kassoumeri L, Knight L, Lambe EJB, Lawrie SM, Lees J, Lewis S, Lythgoe DJ, Matthews J, McGuire P, McNamee L, Semple S, Shaw AD, Singh KD, Stockton-Powdrell C, Talbot PS, Veronese M, Wagner E, Walters JTR, Williams SR, MacCabe JH, Howes OD. Egerton A, et al. Among authors: lees j. Schizophr Bull. 2021 Mar 16;47(2):505-516. doi: 10.1093/schbul/sbaa128. Schizophr Bull. 2021. PMID: 32910150 Free PMC article.
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study.
Millgate E, Kravariti E, Egerton A, Howes OD, Murray RM, Kassoumeri L, Donocik J, Lewis S, Drake R, Lawrie S, Murphy A, Collier T, Lees J, Stockton-Powdrell C, Walters J, Deakin B, MacCabe J. Millgate E, et al. Among authors: lees j. BMJ Open. 2021 Nov 25;11(11):e054160. doi: 10.1136/bmjopen-2021-054160. BMJ Open. 2021. PMID: 34824121 Free PMC article.
Modafinil combined with cognitive training: pharmacological augmentation of cognitive training in schizophrenia.
Michalopoulou PG, Lewis SW, Drake RJ, Reichenberg A, Emsley R, Kalpakidou AK, Lees J, Bobin T, Gilleen JK, Pandina G, Applegate E, Wykes T, Kapur S. Michalopoulou PG, et al. Among authors: lees j. Eur Neuropsychopharmacol. 2015 Aug;25(8):1178-89. doi: 10.1016/j.euroneuro.2015.03.009. Epub 2015 Mar 31. Eur Neuropsychopharmacol. 2015. PMID: 25921551 Clinical Trial.
A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
Rodriguez-Toscano E, López G, Mayoral M, Lewis S, Lees J, Drake R, Arango C, Rapado-Castro M. Rodriguez-Toscano E, et al. Among authors: lees j. Schizophr Res. 2020 Feb;216:347-356. doi: 10.1016/j.schres.2019.11.018. Epub 2019 Dec 6. Schizophr Res. 2020. PMID: 31813804
Calibration and cross-validation of MCCB and CogState in schizophrenia.
Lees J, Applegate E, Emsley R, Lewis S, Michalopoulou P, Collier T, Lopez-Lopez C, Kapur S, Pandina GJ, Drake RJ. Lees J, et al. Psychopharmacology (Berl). 2015 Nov;232(21-22):3873-82. doi: 10.1007/s00213-015-3960-8. Epub 2015 May 29. Psychopharmacology (Berl). 2015. PMID: 26018529 Clinical Trial.
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Koychev I, McMullen K, Lees J, Dadhiwala R, Grayson L, Perry C, Schmechtig A, Walters J, Craig KJ, Dawson GR, Dourish CT, Ettinger U, Wilkinson L, Williams S, Deakin JF, Barkus E. Koychev I, et al. Among authors: lees j. Eur Neuropsychopharmacol. 2012 Jul;22(7):469-81. doi: 10.1016/j.euroneuro.2011.10.005. Epub 2011 Dec 3. Eur Neuropsychopharmacol. 2012. PMID: 22137565 Clinical Trial.
The effects of ketamine and risperidone on eye movement control in healthy volunteers.
Schmechtig A, Lees J, Perkins A, Altavilla A, Craig KJ, Dawson GR, William Deakin JF, Dourish CT, Evans LH, Koychev I, Weaver K, Smallman R, Walters J, Wilkinson LS, Morris R, Williams SC, Ettinger U. Schmechtig A, et al. Among authors: lees j. Transl Psychiatry. 2013 Dec 10;3(12):e334. doi: 10.1038/tp.2013.109. Transl Psychiatry. 2013. PMID: 24326395 Free PMC article. Clinical Trial.
1,059 results